
Arrail Dental Group, China's leading high-end dental care provider with close to a hundred clinics and dental hospitals, announced today that it had completed a $90 million Series D financing. The round was led by Goldman Sachs Group and Hillhouse Capita




Coyote Bioscience, a leading molecular diagnosis company in China, announced today that it had completed Series B financing. The round was led by Northern Light Ventures, with participation from SAIF Asia and Legend Star.

Righton Biology, a specialized molecular diagnostics company with test kits for leukemia, lymphoma, and solid tumors, today announced that it had completed its Series A financing.


Xingshulin, a leading mobile app focused on providing data and management tools to physicians across the country, announced today that it had completed Series C financing.

ET Healthcare, an advanced in-vitro diagnostic technology company, announced today that it had completed a new round of financing, led by Qiming Venture Partners and Masion Capital with participation from the compan's existing shareholders Legend Capital